HADLEIGH BOXFORD GROUP PRACTICE
HADLEIGH HEALTH CENTRE, MARKET PLACE, HADLEIGH, IPSWICHHF 4
The percentage of patients with a current diagnosis of heart failure due to LVD who are currently treated with an ACE inhibitor or Angiotensin Receptor Blocker, who are additionally treated with a beta-blocker licensed for heart failure, or recorded as intolerant to or having a contraindication to beta-blockers.
Indicator | Year | Numerator | Denominator | Ratio | Centile |
---|---|---|---|---|---|
HF 4 | 2010 | 29 | 36 | 80.6% | |
HF 4 | 2011 | 36 | 43 | 83.7% | |
HF 4 | 2012 | 38 | 49 | 77.6% | |
HF 4 | 2013 | 42 | 51 | 82.4% | |
HF004 | 2014 | 20 | 23 | 87.0% | |
HF004 | 2015 | 39 | 41 | 95.1% | |
HF004 | 2016 | 49 | 53 | 92.5% | |
HF004 | 2017 | 52 | 56 | 92.9% | |
HF004 | 2018 | 84 | 99 | 84.8% | |
HF004 | 2019 | 104 | 122 | 85.2% | |
HF004 | 2020 | 103 | 115 | 89.6% | |
HF006 | 2021 | 147 | 178 | 82.6% | |
HF006 | 2022 | 155 | 160 | 96.9% | |
HF006 | 2023 | 159 | 184 | 86.4% |